Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780035 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
Clinical outcomes of pts with primary and recurrent vaginal cancer treated definitively in a systematic manner with combination EBRT with image-guided HDR BT utilizing a MCVC applicator demonstrate high rates of local control and low rates of severe morbidity. The MCVC technique allows interstitial implantation to be avoided in select pts with â¤7â¯mm residual disease thickness following EBRT while maintaining excellent clinical outcomes with extended 4-year follow-up in this rare malignancy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Brian J. Gebhardt, John A. Vargo, Hayeon Kim, Christopher J. Houser, Scott M. Glaser, Paniti Sukumvanich, Alexander B. Olawaiye, Joseph L. Kelley, Robert P. Edwards, John T. Comerci, Madeleine Courtney-Brooks, Sushil Beriwal,